Harvard Bioscience, Inc.
HBIOMedical Instruments & Supplies
$8.90+1.14%As of Oct 30vs prior close
- Market cap
- $40.5M
- P/E (TTM)
- –
- Implied growth
- –
- From 52W high
- 0.00%
- EPS (LTM)
- -$2.27
- Revenue (LTM)
- $87.8M
- Net margin
- -11.86%
- Dividend yield
- 0.00%
Nomior Score
38
Emerging BreakoutSpeculativeBottom 27% of the scored universe
Growth39
Quality38
Value39
Momentum69
Resilience35
Growth
−2.07%revenue a year over 9 fiscal years
YE16 $104.5MLTM $87.8M
Connections
Revenue to profitQ2 YE26
The operating loss was 4% of revenue.
Who owns it
1fund